|
Manufacturers / Sponsors
- Roche Products (trastuzumab)
Patient / Carer Groups
- Afiya Trust
- Black Health Agency
- CANCERactive
- Cancer Black Care
- Cancer Equality
- Chinese National Healthy Living Centre
- Confederation of Indian Organisations
- CORE – The Digestive Disorders Foundation
- Counsel and Care
- Equalities National Council
- Helen Rollason Heal Cancer Charity
- Macmillan Cancer Support
- Maggie's Centres
- Marie Curie Cancer Care
- Muslim Council of Great Britain
- Muslim Health Network
- National Cancer Alliance
- National Council for Palliative Care
- Oesophageal Patients Association
- Rarer Cancers Forum
- S.C.A.N
- South Asian Health Foundation
- Specialised Healthcare Alliance
- Sue Ryder Care
- Tenovus
Professional groups
- Association of Cancer Physicians
- British Association for Services to the Elderly
- British Geriatric Society
- British Institute of Radiology
- British Oncological Association
- British Psychosocial Oncology Society
- British Society of Gastroenterology
- Cancer Networks Pharmacists Forum
- Cancer Research UK
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Pathologists
- Royal College of Physicians, Medical Oncology Joint Special Committee
- Royal College of Radiologists
- Royal Pharmaceutical Society
- Royal Society of Medicine – Intellectual Disabilities Forum
- Society and College of Radiographers
- United Kingdom Clinical Pharmacy Association
- United Kingdom Oncology Nursing Society
Others
- Department of Health
- Kingston PCT
- NHS Halton and St.Helens
- Welsh Assembly Government
|
General
- Board of Community Health Councils in Wales
- British National Formulary
- Commissioning Support Appraisals Service
- Department of Health, Social Services and Public Safety for Northern Ireland
- Medicines and Healthcare products Regulatory Agency
- National Association of Primary Care
- National Public Health Service for Wales
- NHS Alliance
- NHS Confederation
- NHS Purchasing and Supply Agency
- NHS Quality Improvement Scotland
- Scottish Medicines Consortium
Comparator manufacturer(s)
- Actavis (epirubicin, oxaliplatin)
- Bristol-Myers Squibb (cisplatin)
- Cephalon (doxorubicin)
- Hameln Pharmaceuticals (doxorubicin, epirubicin)
- Hospira (epirubicin, 5-FU, cisplatin, oxaliplatin, doxorubicin)
- Medac UK (5-FU, doxorubicin)
- Mylan (oxaliplatin)
- Pfizer (epirubicin, cisplatin, doxorubicin)
- Roche Products (capecitabine)
- Sanofi-Aventis (docetaxel, oxaliplatin,)
- Schering-Plough (doxorubicin)
- Teva UK (cisplatin, doxorubicin, epirubicin, oxaliplatin)
- Wockhardt (cisplatin, doxorubicin, epirubicin, oxaliplatin, 5-FU)
Relevant research groups
- Institute of Cancer Research
- MRC Clinical Trials Unit
- National Cancer Research Institute
- National Cancer Research Network
- National Institute for Health Research
- Policy Research Institute on Ageing and Ethnicity
- Research Institute of the Care of Older People
Evidence Review Group
- Institute of Cancer Research
- MRC Clinical Trials Unit
- National Cancer Research Institute
- National Cancer Research Network
- National Institute for Health Research
- Policy Research Institute on Ageing and Ethnicity
- Research Institute of the Care of Older People
Associated Guideline Groups
- National Collaborating Centre for Cancer
Associated Public Health Groups
|
